1. Home
  2. MOBX vs BYSI Comparison

MOBX vs BYSI Comparison

Compare MOBX & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobix Labs Inc.

MOBX

Mobix Labs Inc.

HOLD

Current Price

$1.70

Market Cap

33.5M

Sector

N/A

ML Signal

HOLD

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

HOLD

Current Price

$0.87

Market Cap

35.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOBX
BYSI
Founded
2020
2010
Country
United States
United States
Employees
46
44
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.5M
35.8M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
MOBX
BYSI
Price
$1.70
$0.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
634.0K
27.8K
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$0.87
52 Week High
$4.25
$2.44

Technical Indicators

Market Signals
Indicator
MOBX
BYSI
Relative Strength Index (RSI) 40.55 23.09
Support Level $0.19 N/A
Resistance Level $2.16 $1.60
Average True Range (ATR) 0.15 0.09
MACD -0.01 -0.02
Stochastic Oscillator 28.57 0.00

Price Performance

Historical Comparison
MOBX
BYSI

About MOBX Mobix Labs Inc.

Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. Its wireless systems solutions include products for RF and millimeter wave (mmWave) communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the defense, aerospace, commercial and industrial sectors. The majority of the company's revenue is derived from product sales to equipment manufacturers. Geographically, it generates the maximum revenue from the United States.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: